Compare MAPS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAPS | XBIT |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | 449 | N/A |
| Industry | Computer Software: Prepackaged Software | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.7M | 71.3M |
| IPO Year | N/A | 2015 |
| Metric | MAPS | XBIT |
|---|---|---|
| Price | $0.66 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.61 | N/A |
| AVG Volume (30 Days) | ★ 685.1K | 45.2K |
| Earning Date | 03-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.17 | N/A |
| P/E Ratio | $9.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $2.09 |
| 52 Week High | $1.36 | $3.62 |
| Indicator | MAPS | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 55.25 |
| Support Level | $0.65 | $2.32 |
| Resistance Level | $0.88 | $2.49 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 36.79 | 82.49 |
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.